Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19683638 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study
Condition: Hypertension
Interventions: Drug: Triatec 10 mg;   Drug: Triatec HCT 5;   Drug: Lasix 25;   Drug: Micardis 80 mg;   Drug: Micardis plus 80/12.5;   Drug: Catapresan TTS 2;   Drug: Norvasc 10 mg;   Drug: Triatec 5 mg;   Drug: Pluscor

Indicates status has not been verified in more than two years